| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 70.44B | 73.31B | 70.01B | 67.73B | 56.79B | 49.98B |
| Gross Profit | 18.51B | 19.73B | 18.12B | 16.50B | 13.56B | 11.99B |
| EBITDA | 7.19B | 8.41B | 6.61B | 6.53B | 5.33B | 4.28B |
| Net Income | 3.32B | 4.69B | 2.81B | 3.60B | 2.48B | 1.52B |
Balance Sheet | ||||||
| Total Assets | 69.41B | 76.79B | 71.71B | 70.10B | 61.00B | 55.05B |
| Cash, Cash Equivalents and Short-Term Investments | 21.20B | 26.32B | 21.90B | 18.94B | 18.02B | 14.77B |
| Total Debt | 5.15B | 4.58B | 5.31B | 5.75B | 5.53B | 5.15B |
| Total Liabilities | 21.05B | 22.68B | 23.23B | 25.76B | 21.95B | 19.50B |
| Stockholders Equity | 45.44B | 50.86B | 45.51B | 41.56B | 36.65B | 33.39B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.09B | 3.92B | 4.02B | 3.11B | 1.00B |
| Operating Cash Flow | 0.00 | 8.71B | 5.71B | 5.33B | 4.17B | 2.10B |
| Investing Cash Flow | 0.00 | -4.75B | -1.38B | -3.90B | -2.51B | -1.46B |
| Financing Cash Flow | 0.00 | -1.63B | -1.45B | -1.70B | -482.00M | -1.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥35.21B | 7.30 | ― | 1.78% | 4.70% | 66.89% | |
74 Outperform | ¥74.62B | 14.81 | ― | 3.17% | 4.65% | 5.17% | |
73 Outperform | ¥154.63B | 9.94 | ― | 1.72% | 46.71% | 77.52% | |
73 Outperform | ¥52.36B | 9.93 | ― | 3.00% | 5.40% | 8.39% | |
68 Neutral | ¥105.55B | 14.61 | ― | 3.38% | 15.74% | -3.66% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥146.79B | 9.32 | ― | 2.42% | 8.46% | -3.62% |